Dr. Martens (LON:DOCS) Sets New 1-Year High After Analyst Upgrade

Key Points

Error: Response status code does not indicate success: 429 (Too Many Requests).

Dr. Martens plc (LON:DOCS - Get Free Report) shares reached a new 52-week high during mid-day trading on Tuesday after Peel Hunt upgraded the stock to a buy rating. The company traded as high as GBX 86 ($1.16) and last traded at GBX 85.54 ($1.16), with a volume of 1096627 shares. The stock had previously closed at GBX 81.05 ($1.09).

Other equities analysts also recently issued reports about the stock. Deutsche Bank Aktiengesellschaft reissued a "hold" rating on shares of Dr. Martens in a report on Friday, July 11th. Royal Bank Of Canada cut their price target on shares of Dr. Martens from GBX 7,000 to GBX 6,000 and set a "sector perform" rating on the stock in a report on Monday, May 19th. One investment analyst has rated the stock with a Buy rating and two have given a Hold rating to the company's stock. According to MarketBeat, Dr. Martens has a consensus rating of "Hold" and an average price target of GBX 6,000.

Dr. Martens Stock Performance

The company's fifty day simple moving average is GBX 77.48 and its 200 day simple moving average is GBX 65.30. The firm has a market capitalization of £821.27 million, a PE ratio of 11.99, a P/E/G ratio of 6.40 and a beta of 0.11. The company has a debt-to-equity ratio of 127.27, a current ratio of 2.85 and a quick ratio of 1.13.

Dr. Martens (LON:DOCS - Get Free Report) last announced its quarterly earnings results on Thursday, June 5th. The company reported GBX 2.40 earnings per share for the quarter. Dr. Martens had a return on equity of 18.91% and a net margin of 7.89%. As a group, equities research analysts expect that Dr. Martens plc will post 2.5809394 EPS for the current fiscal year.

About Dr. Martens

Founded in 1960, Dr. Martens is an iconic British brand with a global presence. “Docs” or “DMs” were originally produced for their durability for workers, before being adopted by diverse youth subcultures and associated musical movements. Today, Dr. Martens has transcended its roots while still celebrating its proud history.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.